Product Code: TMRGL81706
Advanced Glycation End Products Market - Scope of Report
TMR's report on the global advanced glycation end products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global advanced glycation end products market for the period from 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global advanced glycation end products market from 2021 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the advanced glycation end products market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global advanced glycation end products market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global advanced glycation end products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global advanced glycation end products market.
The report delves into the competitive landscape of the global advanced glycation end products market. Key players operating in the global advanced glycation end products market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global advanced glycation end products market profiled in this report.
Key Questions Answered in Advanced Glycation End Products Market Report
What is the sales/revenue generated by the advanced glycation end products market across all regions during the forecast period?
What are the opportunities in the global advanced glycation end products market?
What are the major drivers, restraints, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which type segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Advanced Glycation End Products Market - Research Objectives and Research Approach
The comprehensive report on the global advanced glycation end products market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global advanced glycation end products market in terms of type, application, end user, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global advanced glycation end products market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Advanced Glycation End Products Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Advanced Glycation End Products Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Bioactivity of AGEs and RAGE: Flowchart
- 5.2. Key Trend Analysis
- 5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Advanced Glycation End Products Market Analysis and Forecast, by Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Global Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
- 6.3.1. Non-fluorescent AGEs
- 6.3.1.1. Carboxymethyl-lysine (CML)
- 6.3.1.2. Carboxyethyl-lysine (CEL)
- 6.3.1.3. Pyrraline
- 6.3.2. Fluorescent AGEs
- 6.3.2.1. Pentosidine
- 6.3.2.2. Methylglyoxal-lysine dimer (MOLD)
- 6.4. Global Advanced Glycation End Products Market Attractiveness, by Type
7. Global Advanced Glycation End Products Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Global Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
- 7.3.1. Diabetic Complications
- 7.3.2. Cancer
- 7.3.3. Bone Diseases
- 7.3.4. Neurodegenerative Diseases
- 7.3.5. Others
- 7.4. Global Advanced Glycation End Products Market Attractiveness, by Application
8. Global Advanced Glycation End Products Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Global Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics
- 8.3.3. Others
- 8.4. Global Advanced Glycation End Products Market Attractiveness, by End-user
9. Global Advanced Glycation End Products Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Global Advanced Glycation End Products Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Global Advanced Glycation End Products Market Attractiveness, by Country/Region
10. North America Advanced Glycation End Products Market Analysis and Forecast
- 10.1. Introduction
- 10.2. North America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
- 10.2.1. Non-fluorescent AGEs
- 10.2.1.1. Carboxymethyl-lysine (CML)
- 10.2.1.2. Carboxyethyl-lysine (CEL)
- 10.2.1.3. Pyrraline
- 10.2.2. Fluorescent AGEs
- 10.2.2.1. Pentosidine
- 10.2.2.2. Methylglyoxal-lysine dimer (MOLD)
- 10.3. North America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
- 10.3.1. Diabetic Complications
- 10.3.2. Cancer
- 10.3.3. Bone Diseases
- 10.3.4. Neurodegenerative Diseases
- 10.3.5. Others
- 10.4. North America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Specialty Clinics
- 10.4.3. Others
- 10.5. North America Advanced Glycation End Products Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. North America Advanced Glycation End Products Market Attractiveness Analysis
- 10.6.1. By Type
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Advanced Glycation End Products Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Europe Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
- 11.2.1. Non-fluorescent AGEs
- 11.2.1.1. Carboxymethyl-lysine (CML)
- 11.2.1.2. Carboxyethyl-lysine (CEL)
- 11.2.1.3. Pyrraline
- 11.2.2. Fluorescent AGEs
- 11.2.2.1. Pentosidine
- 11.2.2.2. Methylglyoxal-lysine dimer (MOLD)
- 11.3. Europe Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
- 11.3.1. Diabetic Complications
- 11.3.2. Cancer
- 11.3.3. Bone Diseases
- 11.3.4. Neurodegenerative Diseases
- 11.3.5. Others
- 11.4. Europe Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Specialty Clinics
- 11.4.3. Others
- 11.5. Europe Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Europe Advanced Glycation End Products Market Attractiveness Analysis
- 11.6.1. By Type
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Advanced Glycation End Products Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
- 12.2.1. Non-fluorescent AGEs
- 12.2.1.1. Carboxymethyl-lysine (CML)
- 12.2.1.2. Carboxyethyl-lysine (CEL)
- 12.2.1.3. Pyrraline
- 12.2.2. Fluorescent AGEs
- 12.2.2.1. Pentosidine
- 12.2.2.2. Methylglyoxal-lysine dimer (MOLD)
- 12.3. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
- 12.3.1. Diabetic Complications
- 12.3.2. Cancer
- 12.3.3. Bone Diseases
- 12.3.4. Neurodegenerative Diseases
- 12.3.5. Others
- 12.4. Asia Pacific Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Specialty Clinics
- 12.4.3. Others
- 12.5. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Asia Pacific Advanced Glycation End Products Market Attractiveness Analysis
- 12.6.1. By Type
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Advanced Glycation End Products Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Latin America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
- 13.2.1. Non-fluorescent AGEs
- 13.2.1.1. Carboxymethyl-lysine (CML)
- 13.2.1.2. Carboxyethyl-lysine (CEL)
- 13.2.1.3. Pyrraline
- 13.2.2. Fluorescent AGEs
- 13.2.2.1. Pentosidine
- 13.2.2.2. Methylglyoxal-lysine dimer (MOLD)
- 13.3. Latin America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
- 13.3.1. Diabetic Complications
- 13.3.2. Cancer
- 13.3.3. Bone Diseases
- 13.3.4. Neurodegenerative Diseases
- 13.3.5. Others
- 13.4. Latin America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Specialty Clinics
- 13.4.3. Others
- 13.5. Latin America Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Latin America Advanced Glycation End Products Market Attractiveness Analysis
- 13.6.1. By Type
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Advanced Glycation End Products Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
- 14.2.1. Non-fluorescent AGEs
- 14.2.1.1. Carboxymethyl-lysine (CML)
- 14.2.1.2. Carboxyethyl-lysine (CEL)
- 14.2.1.3. Pyrraline
- 14.2.2. Fluorescent AGEs
- 14.2.2.1. Pentosidine
- 14.2.2.2. Methylglyoxal-lysine dimer (MOLD)
- 14.3. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
- 14.3.1. Diabetic Complications
- 14.3.2. Cancer
- 14.3.3. Bone Diseases
- 14.3.4. Neurodegenerative Diseases
- 14.3.5. Others
- 14.4. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Specialty Clinics
- 14.4.3. Others
- 14.5. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Middle East & Africa Advanced Glycation End Products Market Attractiveness Analysis
- 14.6.1. By Type
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Share Analysis, by Company (2020)
- 15.2. Company Profiles
- 15.2.1. AbbVie, Inc. (Allergan Plc)
- 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.1.2. Company Financials
- 15.2.1.3. Growth Strategies
- 15.2.1.4. SWOT Analysis
- 15.2.2. Merck KGaA
- 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.2.2. Company Financials
- 15.2.2.3. Growth Strategies
- 15.2.2.4. SWOT Analysis
- 15.2.3. Takeda Pharmaceutical Company Limited
- 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.3.2. Company Financials
- 15.2.3.3. Growth Strategies
- 15.2.3.4. SWOT Analysis
- 15.2.4. Estee Lauder Companies
- 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.4.2. Company Financials
- 15.2.4.3. Growth Strategies
- 15.2.4.4. SWOT Analysis
- 15.2.5. Shiseido Company, Limited
- 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.5.2. Company Financials
- 15.2.5.3. Growth Strategies
- 15.2.5.4. SWOT Analysis
- 15.2.6. Beiersdorf AG
- 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.6.2. Company Financials
- 15.2.6.3. Growth Strategies
- 15.2.6.4. SWOT Analysis
- 15.2.7. L'Oreal S.A.
- 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.7.2. Company Financials
- 15.2.7.3. Growth Strategies
- 15.2.7.4. SWOT Analysis
- 15.2.8. NuFACE
- 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.8.2. Company Financials
- 15.2.8.3. Growth Strategies
- 15.2.8.4. SWOT Analysis
- 15.2.9. Rodan & Fields
- 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.9.2. Company Financials
- 15.2.9.3. Growth Strategies
- 15.2.9.4. SWOT Analysis
- 15.2.10. PhotoMedex, Inc.
- 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.10.2. Company Financials
- 15.2.10.3. Growth Strategies
- 15.2.10.4. SWOT Analysis
- 15.2.11. Ostium Cosmetics
- 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.11.2. Company Financials
- 15.2.11.3. Growth Strategies
- 15.2.11.4. SWOT Analysis
- 15.2.12. Cell Biolabs, Inc.
- 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.12.2. Company Financials
- 15.2.12.3. Growth Strategies
- 15.2.12.4. SWOT Analysis
- 15.2.13. Shanghai Korain Biotech Co., Ltd.
- 15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.13.2. Company Financials
- 15.2.13.3. Growth Strategies
- 15.2.13.4. SWOT Analysis